D r i v e n .
F o r L i f e .
Through our team spirit, expertise and dedication,
we strive to take on challenges and explore new
possibilities to enrich human life through
technology and innovation.
Samsung Biologics is a fully integrated, end-to-end CDMO service provider offering seamless development and manufacturing solutions from cell line development to final aseptic fill/finish as well as laboratory testing services at every stage for biopharmaceutical products. Our facilities are all cGMP compliant with bioreactors ranging from small to large scales to serve varying client needs.
To maximize our operational efficiency and expand our capabilities in response to growing biomanufacturing demands, Samsung Biologics launched Plant 4, which will further advance the company’s standing as the world’s largest manufacturing facility at a single site—holding a 604KL total capacity—and announced plans to construct Plant 5, which will be operational in 2025.
As a sustainable CDMO partner of choice, we are committed to on-time, in-full delivery of the products we manufacture with our flexible manufacturing solutions, operational excellence, and proven expertise.
Because we understand the dynamic nature of the healthcare industry and unpredictable nature of disease, we're driven to evolve for the needs of our partners and the patients they serve.
Our mission is to become the most trusted partner to our clients working together to achieve Better Life for humanity through biomedicines.
With innovation, passion, and an unwavering dedication, we pursue breakthrough solutions to build a more sustainable future and improve the lives of millions around the world.